NPCE (NeuroPace, Inc.) Market Capitalization

This price chart for NeuroPace, Inc. (NPCE) illustrates the price action of an asset with a market capitalization of 0.43. Supply chains for the procurement of electrodes and chips are fully optimized due to counterparty diversification. Revenue growth is driven by the mass adoption of stimulators and their approval by insurance funds. The business relies on an exclusive automatic seizure suppression system that independently detects pathological activity.

NeuroPace Inc - NPCE Market Value (period 07/04/2022 - 11/12/2026)

Comprehensive metric breakdowns and analytics for NeuroPace Medical (NPCE)

- market price and analyst price targets:

Price Chart NeuroPace|NPCE - Forecast Levels Chart

- business market valuation indicators:

Market Capitalization NeuroPace Medical|NPCE - Real Price to Acquire Entire Company

- issuer book value statistics:

Book Value per Share NeuroPace|NPCE - Total Stockholders' Equity|Market Cap to Net Assets Ratio neuropace.com|NPCE - Aggregate Business Assets

- debt level and financial liquidity data:

- financial results and valuation multiples details:

NPCE - Profit After Tax|Projected Future Earnings NeuroPace, Inc.|NPCE - Market Cap to Earnings|Projected Price to Earnings NeuroPace Corp|NPCE - PEG Multiple|Enterprise Value to EBITDA Ratio NeuroPace Medical|NPCE - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) NeuroPace|NPCE - Net earnings per share for the last four quarters|Quarterly EPS earnings growth neuropace.com|NPCE - Net earnings per share growth this year|Expected earnings per share growth for next year NeuroPace, Inc.

Initial company analysis:NPCE (NeuroPace)

Market capitalization represents the aggregate value of all shares, reflecting the current scale of the business via the market price. Investors utilize this indicator to assess liquidity and determine an asset's growth potential. By analyzing a company's market capitalization on the exchange, one can compare the size of the firm against its sector competitors. For NeuroPace, Inc. (NPCE), this metric confirms the resilience of the business. Low geopolitical risks and a focus on US healthcare support valuation stability.

Key competitors